| Relation | Metric | Value | YoY |
|---|
Where did the money come from, and where was it spent?
Revenue grew while operating profit fell, so growth did not translate into better earnings.
Operating margin declined by 4.63 percentage points year over year.
- Revenue
- USD 23.76B YoY +10.50%
- Largest revenue segment share (Medical Devices)
- 47.95% YoY +0.21pp
- Cost of revenue
- USD 10.21B Share 43.00% · YoY +9.58%
- Selling, general and administrative
- USD 7.76B Share 32.69% · YoY +26.22%
View calculation evidence
YoY periods: H1 2026 compared with H1 2025
Source metrics
- RevenueNet sales · RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenueCost of products sold, excluding amortization of intangible assets · CostOfGoodsAndServicesSold
- Selling, general and administrativeSelling, general, and administrative · SellingGeneralAndAdministrativeExpense
- Largest revenue segment share (Medical Devices)Medical Devices · segment_value / revenue * 100
- Operating marginOperating earnings · operating_income / revenue * 100